心臟移植市場規模、佔有率和成長分析（按類型、最終用戶和地區）- 產業預測 2025-2032

Heart Transplant Market Size, Share, Growth Analysis, By Type (Ventricular Assist Devices, Total Artificial Hearts), By End User (Hospitals, Cardiac Institutes), By Region - Industry Forecast 2025-2032

出版日期: 2025年01月09日 | 出版商:

SkyQuest | 英文 223 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年全球心臟移植市場規模價值為 116 億美元，預計將從 2024 年的 128.2 億美元成長到 2032 年的 284.9 億美元，預測期內（2025-2032 年）的複合年成長率為 10.5%。

受末期心臟疾病發病率上升的推動，全球心臟移植市場正在經歷顯著成長，從而刺激了對心臟移植這項關鍵的救生手術的需求。手術技術、免疫抑制療法和器官保存策略的重大技術進步進一步推動了市場擴張。然而，捐贈心臟的持續短缺已成為一個重大問題，凸顯了改善器官採購方法和審查移植標準的必要性。持續的研究舉措和醫學界的合作對於改善患者的治療效果和解決心臟移植的複雜問題至關重要。隨著市場的發展，應對這些挑戰對於推動這一重要領域的永續成長和改善整體醫療保健解決方案至關重要。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前 5 家公司對比
主要企業市場定位（2024年）
主要市場參與者所採用的策略
近期市場趨勢
公司市場佔有率分析（2024 年）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分析市場佔有率
- 收益與前一年同期比較（2022-2024 年）

主要企業簡介

Optum Inc.（USA）
Novartis Pharmaceuticals UK Ltd.（UK）
Abbott Laboratories（USA）
Medtronic PLC（Ireland）
Stryker Corporation（USA）
Roche Diagnostics Ltd.（Switzerland）
Mayo Clinic（USA）
Cleveland Clinic（USA）
AstraZeneca PLC（UK）
Massachusetts General Hospital（USA）
Terumo Corp.（Japan）
NewYork-Presbyterian Hospital（USA）
Cedars-Sinai Medical Center（USA）
Maquet Holding BV and Co. KG.（Germany）
Teleflex Inc.（USA）
Stanford Health Care（USA）
Johns Hopkins Hospital（USA）
Thoratec Corporation（USA）
Abiomed Inc.（USA）
Baylor St. Luke's Medical Center（USA）

結論和建議

簡介目錄

Product Code: SQMIG35D2230

Global Heart Transplant Market size was valued at USD 11.6 billion in 2023 and is poised to grow from USD 12.82 billion in 2024 to USD 28.49 billion by 2032, growing at a CAGR of 10.5% during the forecast period (2025-2032).

The global heart transplant market is experiencing significant growth, driven by the rising prevalence of end-stage heart diseases, which fuels demand for heart transplants as critical, life-saving procedures. Key technological advancements in surgical techniques, immunosuppressive therapies, and organ preservation strategies are further propelling market expansion. However, a persistent shortage of donor hearts poses a major challenge, highlighting the need for improved organ procurement methods and revised transplantation criteria. Ongoing research initiatives and collaborations within the medical community are essential for enhancing patient outcomes and tackling the complex issues surrounding heart transplantation. As the market evolves, addressing these challenges will be crucial for fostering sustainable growth and improving overall healthcare solutions in this critical domain.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Heart Transplant market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Heart Transplant Market Segmental Analysis

Global Heart Transplant Market is segmented by Type, End User and region. Based on Type, the market is segmented into Ventricular Assist Devices, Total Artificial Hearts and Others. Based on End User, the market is segmented into Hospitals, Cardiac Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Heart Transplant Market

The Global Heart Transplant market is primarily driven by the rising demand for heart transplants, which is largely fueled by the escalating prevalence of end-stage heart diseases worldwide. This increasing need is complemented by significant advancements in surgical techniques, immunosuppressive therapies, and organ preservation methods, all of which enhance the feasibility and success rates of heart transplant procedures. As healthcare systems adapt to these innovations, the market continues to expand, responding to the urgent requirements of patients and improving overall outcomes in heart transplantation. These factors collectively contribute to the robust growth of the heart transplant sector on a global scale.

Restraints in the Global Heart Transplant Market

A significant constraint affecting the global heart transplant market is the ongoing and substantial shortage of donor organs, particularly viable hearts. This persistent deficiency severely restricts the number of transplant procedures that can be conducted. Additionally, the intricacies involved in the logistics of organ procurement, preservation, and transportation further complicate the process. The challenges associated with securing donor organs not only impact the availability for transplantation but also hinder advancements in surgical techniques and overall patient outcomes. This combination of limited supply and operational difficulties poses a major obstacle in meeting the growing demand for heart transplants.

Market Trends of the Global Heart Transplant Market

The Global Heart Transplant market is witnessing a significant shift towards advanced technologies, particularly genetic testing and regenerative medicine, enhancing organ viability and transplant outcomes. Innovations such as normothermic machine perfusion are improving the preservation of donor hearts, while stem cell therapies are being explored to reduce rejection risks. Additionally, the integration of telemedicine and remote monitoring solutions is transforming post-transplant care, ensuring continuous health management for patients. This trend reflects a broader commitment to optimizing heart transplant procedures and patient outcomes, ultimately expanding the market's growth potential and improving the quality of life for recipients.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Heart Transplant Market Size by Type & CAGR (2025-2032)

Market Overview
Ventricular Assist Devices
Total Artificial Hearts
Others

Global Heart Transplant Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Cardiac Institutes
Others

Global Heart Transplant Market Size & CAGR (2025-2032)

North America (Type, End User)
- US
- Canada
Europe (Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Optum Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis Pharmaceuticals UK Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mayo Clinic (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cleveland Clinic (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Massachusetts General Hospital (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corp. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NewYork-Presbyterian Hospital (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cedars-Sinai Medical Center (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Maquet Holding B.V. and Co. KG. (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stanford Health Care (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johns Hopkins Hospital (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thoratec Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abiomed Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baylor St. Luke's Medical Center (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments